Literature DB >> 18049450

Polymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma.

Chunying Li, Kexin Chen, Zhensheng Liu, Li-E Wang, Jeffrey E Gershenwald, Jeffrey E Lee, Victor G Prieto, Madeleine Duvic, Elizabeth A Grimm, Qingyi Wei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18049450      PMCID： PMC2938047          DOI： 10.1038/sj.jid.5701186

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  18 in total

1.  A possible role of p73 on the modulation of p53 level through MDM2.

Authors:  X Q Wang; W M Ongkeko; A W Lau; K M Leung; R Y Poon
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

2.  p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma.

Authors:  Hongbing Shen; Zhensheng Liu; Sara S Strom; Margaret R Spitz; Jeffrey E Lee; Jeffrey E Gershenwald; Merrick I Ross; Paul F Mansfield; Madeleine Duvic; Honnavara N Ananthaswamy; Qingyi Wei
Journal:  J Invest Dermatol       Date:  2003-12       Impact factor: 8.551

3.  DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma.

Authors:  Joanne E Povey; Fatemeh Darakhshan; Karen Robertson; Yvonne Bisset; Magda Mekky; Jonathan Rees; Val Doherty; Gina Kavanagh; Niall Anderson; Harry Campbell; Rona M MacKie; David W Melton
Journal:  Carcinogenesis       Date:  2007-01-08       Impact factor: 4.944

Review 4.  The p53 gene family.

Authors:  W G Kaelin
Journal:  Oncogene       Date:  1999-12-13       Impact factor: 9.867

5.  Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.

Authors:  M Kaghad; H Bonnet; A Yang; L Creancier; J C Biscan; A Valent; A Minty; P Chalon; J M Lelias; X Dumont; P Ferrara; F McKeon; D Caput
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

Review 6.  p53-mediated apoptosis and genomic instability diseases.

Authors:  A I Robles; C C Harris
Journal:  Acta Oncol       Date:  2001       Impact factor: 4.089

7.  p21 is a universal inhibitor of cyclin kinases.

Authors:  Y Xiong; G J Hannon; H Zhang; D Casso; R Kobayashi; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

8.  p73 G4C14-to-A4T14 polymorphism and risk of lung cancer.

Authors:  Guojun Li; Li-E Wang; Robert M Chamberlain; Christopher I Amos; Margaret R Spitz; Qingyi Wei
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

9.  Alterations of DeltaTA-p 73 splice transcripts during melanoma development and progression.

Authors:  Sebastian Tuve; Stephan N Wagner; Birgit Schittek; Brigitte M Pützer
Journal:  Int J Cancer       Date:  2004-01-01       Impact factor: 7.396

10.  Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas.

Authors:  M J Vidal; F Loganzo; A R de Oliveira; N K Hayward; A P Albino
Journal:  Melanoma Res       Date:  1995-08       Impact factor: 3.599
View more
  10 in total

1.  Assessment of the XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro) and GSTP1 (Ile105Val) polymorphisms in the risk of cutaneous melanoma.

Authors:  Cristiane Oliveira; José Augusto Rinck-Junior; Gustavo Jacob Lourenço; Aparecida Machado Moraes; Carmen Silvia Passos Lima
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-09       Impact factor: 4.553

2.  Combined analysis of the association between p73 G4C14-to-A4T14 polymorphisms and cancer risk.

Authors:  Lan Wang; Rui Gao; Long Yu
Journal:  Mol Biol Rep       Date:  2011-05-27       Impact factor: 2.316

3.  Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas.

Authors:  Keith R Loeb; Maryam M Asgari; Stephen E Hawes; Qinghua Feng; Joshua E Stern; Mingjun Jiang; Zsolt B Argenyi; Ethel-Michele de Villiers; Nancy B Kiviat
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

4.  Increased risk of cutaneous melanoma associated with p53 Arg72Pro polymorphism.

Authors:  Peiliang Geng; Yunmei Liao; Zhihua Ruan; Houjie Liang
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

5.  Association between p21 Ser31Arg polymorphism and cancer risk: a meta-analysis.

Authors:  Hongxia Ma; Ziyuan Zhou; Sheng Wei; Qingyi Wei
Journal:  Chin J Cancer       Date:  2011-04

6.  TP73 G4C14-A4T14 polymorphism and cancer susceptibility: evidence from 36 case-control studies.

Authors:  Jialin Meng; Shuo Wang; Meng Zhang; Song Fan; Li Zhang; Chaozhao Liang
Journal:  Biosci Rep       Date:  2018-12-14       Impact factor: 3.840

7.  The complementary effect of rs1042522 in TP53 and rs1805007 in MC1R is associated with an elevated risk of cutaneous melanoma in Latvian population.

Authors:  Aija Ozola; Dace Ruklisa; Dace Pjanova
Journal:  Oncol Lett       Date:  2019-09-20       Impact factor: 2.967

8.  Arg72Pro polymorphism of TP53 gene and the risk of skin cancer: a meta-analysis.

Authors:  Jun Ye; Xiao-Fen Li; Yong-Dong Wang; Ying Yuan
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

9.  Role of p73 Dinucleotide Polymorphism in Prostate Cancer and p73 Protein Isoform Balance.

Authors:  L Michael Carastro; Hui-Yi Lin; Hyun Y Park; Donghwa Kim; Selina Radlein; Kaia K Hampton; Ardeshir Hakam; Babu Zachariah; Julio Pow-Sang; Jong Y Park
Journal:  Prostate Cancer       Date:  2014-07-06

10.  TP53 Gene Polymorphisms and Occupational Skin Cancer Risks for Workers of Glass Fiber Manufacture.

Authors:  Guzel F Mukhammadiyeva; Denis O Karimov; Akhat B Bakirov; Liliya K Karimova
Journal:  Iran J Public Health       Date:  2017-11       Impact factor: 1.429
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.